[taylor&francis] Byakangelicin alleviates metabolic dysfunction-associated steatohepatitis by selective inhibition of a non-canonical MTORC1 signaling pathway |
10
Mammalian lipophagy: process and function
30
Current advances in colorectal cancer treatment: a review of recent clinical trials
10
Byakangelicin alleviates metabolic dysfunction-associated steatohepatitis by selective inhibition of a non-canonical MTORC1 signaling pathway
10
Trade-off and synergy analysis among ecosystem services in a karst watershed
10
Current advances in colorectal cancer treatment: a review of recent clinical trials
